Aimei Health Technology Receives Nasdaq Delisting Notice for Delayed 10-K Filing

summarizeSummary

Aimei Health Technology Co., Ltd. received a Nasdaq deficiency notice for failing to timely file its Annual Report on Form 10-K, initiating a 60-day period to regain compliance and avoid potential delisting.

check_boxKey Events

• Nasdaq Deficiency Notice Received

  On April 17, 2026, Aimei Health Technology Co., Ltd. received a notice from Nasdaq for failing to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was due on March 31, 2026.

• Compliance Deadline Set

  The company has 60 calendar days from April 17, 2026, to either file the overdue Annual Report or submit a plan to Nasdaq to regain compliance. If accepted, an extension of up to 180 calendar days from the original due date may be granted.

• Potential Delisting Risk

  Failure to timely regain compliance with Nasdaq's listing rules could result in the delisting of the company's securities from The Nasdaq Stock Market LLC.

• Company Working Towards Compliance

  Aimei Health Technology Co., Ltd. stated it is working diligently to complete and file the Annual Report and expects to regain compliance with the Listing Rule.

auto_awesomeAnalysis

Aimei Health Technology Co., Ltd. has received a formal notice from Nasdaq regarding non-compliance with listing rules due to its failure to timely file the Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This is a critical event as it initiates a process that could lead to the delisting of the company's securities from Nasdaq if compliance is not regained. While the company has 60 days to submit a plan and potentially up to 180 days for compliance, the deficiency raises significant concerns about the company's financial reporting and operational stability, which could impact investor confidence and the company's ability to complete its business combination as a blank check company.